Medicine Recall Alert: DDCP Issues Recall of Four Substandard Drug Products
URGENT MEDICINE RECALL ALERTS: DRUGS CONTROL DEPARTMENT, PUNJAB FLAGS FOUR MEDICINAL PRODUCTS AS SUBSTANDARD Three public notices issued by the
Pharma Bulletin
DRAP-Issued Rapid Alerts Regarding Spurious and Falsified Medications – 27 October 2026
DRAP-Issued Rapid Alerts Regarding Spurious and Falsified Medications – 27 October 2026 The Drug Regulatory Authority of Pakistan (DRAP) issued
Directorate of Drugs Control (DDC), Punjab — Drug Alerts: Class I & II Recalls and Prompt Alert
Directorate of Drugs Control (DDC), Punjab — Drug Alerts: Class I & II Recalls and Prompt Alert On 12 October
DDCP Issues Multiple Medicine Recall and Prompt Alerts of Class-I and Class-II Categories
DDCP Issues Multiple Medicine Recall and Prompt Alerts of Class-I and Class-II Categories The Directorate of Drugs Control (DDCP), Punjab,
Recall Alert of Substandard batches of Lowplat plus Tablets | Issued by DDC punjab
Recall Alert of Substandard batches of Lowplat plus Tablets || Issued by DDC punjab Lowplat Plus Tablet is a film-coated,
FDA’s Final Order Regarding PABA and Trolamine Salicylate in Sunscreens
FDA Final Order of September 10, 2026, Removing PABA and Trolamine Salicylate from the U.S. OTC Sunscreen Monograph The U.S.
Rapid Alert – Spurious Drug Products (NOVIDAT 500 mg Tablets and TONOFLEX-P Tablets)
Rapid Alert – Spurious Drug Products (NOVIDAT 500 mg Tablets and TONOFLEX-P Tablets) On 3rd June DRAP issued Rapid Alert
DRAP Issues Rapid Alert on Spurious Brexin Tablets and Danzen DS Batches
DRAP Issues Rapid Alert on Spurious Brexin Tablets and Danzen DS Batches 💊Rapid Alert – Spurious/Falsified Brexin Tablets 20 mg
Multiple Rapid and Recall Alerts for Spurious and Substandard Medications issued by DRAP
Multiple Rapid and Recall Alerts ⚠️ for Spurious and Substandard Medications issued by DRAP 1. Rapid Alert – Spurious Terbiderm
Osilex-D Tablet (Glitz Pharma) – Voluntary Recall Alert
Osilex-D Tablet (Glitz Pharma) – Voluntary Recall Alert Voluntary Recall of Drug Product – Osilex-D (Glitz Pharma) DRAP Alert No.:
Teczone Forte injection: DRAP Recall (Class-I) Substandard batch of Teczone forte injection
DRAP Recall Alert (Class-I): Substandard batch of Teczone forte injection has been recalled by DRAP On February 25, 2026 Central
DRAP’s Rapid Alert-Unregistered Antiseptic Chloroxylenol Liquid Brand
DRAP’s Rapid Alert-Unregistered Antiseptic Chloroxylenol Liquid Brand Rapid Alert – Unregistered Antiseptic Product “Zetol (Chloroxylenol) Germ Protection Liquid” DRAP Alert
DRAP Recall Alert: Multiple Substandard & Adulterated Batches of Common Medications are Recalled
DRAP Recall Alert⚠️: Multiple Substandard & Adulterated Batches of Common Medications are Recalled by DRAP as CLASS-II & CLASS-I recalls
Isotretinoin: Safety Alert issued by Health Canada and DRAP-PRAEC
Isotretinoin: Safety Alert issued by Health Canada and DRAP-PRAEC What is Isotretinoin? Isotretinoin is a retinoid used orally for the
Safety Alert Regarding Cotrimoxazole (Sulfamethoxazole and Trimethoprim) issued by DRAP and EMA-PRAC
Safety Alert Regarding Cotrimoxazole (Sulfamethoxazole and Trimethoprim) issued by DRAP and PRAC-EMA Target Audience Provincial Health Departments / Provincial Pharmacovigilance
Finasteride and Dutasteride Safety Alerts Issued by DRAP
Finasteride and Dutasteride Safety Alerts Issued by Drug Regulatory Authority of Pakistan (DRAP) Safety Alert on the Potential Risk of
DRAP’s Safety Alert Regarding Mesalazine
DRAP’s Safety Alert Regarding Mesalazine! Risk of Idiopathic Intracranial Hypertension Associated with Mesalazine Date: 30 January 2026 Idiopathic Intracranial hypertension:
DRAP issued Rapid Alert of Spurious Medicine
On 23rd january 2026, DRAP issued a Rapid Alert of Spurious Tablet EFASTON® DRAP Alert No: No I/S/01-26-136 Action Date:
DRAP’s Multiple Recalls Alerts About Adulterated, Substandard & Misbranded Medicines
DRAP’s Multiple Recalls Alerts About Adulterated, Substandard & Misbranded Medicines Recall Alert (Class-I) – BP-NORM Tablets (Substandard & Adulterated) DRAP
DRAP’s Multiple Recall Alerts of January-14, 2026
DRAP RAPID ALERT: UNREGISTERED & FALSIFIED COSMETIC AND TOPICAL PRODUCTS CONTAINING UNAUTHORIZED PHARMACEUTICAL INGREDIENTS DRAP Alert No: I/S/01-26-128Action Date: 14